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In a study of drug AT-demethy~ations in isolated 
hepatocytes and perfused rat liver, we have observed 
a substantiaI stimulation of B4C02 formation from 
~~~;P2e~l~yl~??zir?o-‘4C]aminopyrine upon addition of 
i-methionine [I ]_ This is in agreement with the results 
of studies tin the role of methionine in the metabolism 
of CI -tiMis derived from histidine [L&4] at?d f&mate 
141. An explanation of the mezhionine effects is 
provided by its.conversion to S-adenosyl methionine 
(scheme I) which reduces the formation of methyl- 
tetrahydrofolate by inhibition of methylene tetra- 
hydrofolate reductase [5]. This provides an increased 
proportion of retrahydrofolate whkh functions in the 
Scheme 1 
THF, tetrahydrofolate 
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degradation of forminogjutamate and the oxidation 
of for-mate to carbon dioxide by folatc-dependent 
pathways [6] (scheme I>. 
The thyroid state has been shown to affect folic 
acid and vitamin Blz ‘metabolism [73. The effect of 
hyperthyroidim in increasing the excretion of 
forminoghztamic acid and decreasing the oxidation of 
[2-‘4C]histidine to “C02 has been identified as due 
mainly to an increase in methylenetetrahydrofolate 
rzductase [8,9] which would increase the production 
of rnet~irrl-tetrah)rdrofoIate and thereby decrease the 
non-methyl’tetrabydrofolates which can function in 
formate oxidation by the folate-dependent pathway 
(scheme 1) and in the degradation of forminoglutarnic 
acid. Production ofhypothyroidism by either feeding 
ofthyroid inhibitors (thiouracil) or by thyroidectomy 
increases histidine oxidation to CO2 and reduces 
excretion of forminoghrtamic acid [8,9]. 
The exhalation of r4C02 derived from [dimetlzyl- 
mnitlo- r4C]amiiiopyrine [I 01 has been evaluated as a 
non-invasive assay of the drug-metabolizing capacity 
of the Iiver in animals and in man in the so-called 
‘breath test’ [ 1 l-14]. 1 n order to assess the possible 
significance of the above-mentioned observations 
[ 1-83 on the aminopyrine breath test i we !lave 
examined the effects oflow rnethionine diet aj>d of 
thyroid status on ‘“CO2 exhalation rates in rats given 
[diltzetlt~71ar7zirro-~4 C]aminoyyrine. The results show 
+hat in phenobarbital-treated animals there is a marked 
stinmlatory effect due to methionine and, further, an 
increased rate of *4C02 exhalation is produced by 
thyroidectomy or feeding thiouracil. 
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Mate Wistar or Sprague Dawley rats (90-l 30 gj as 
indicated which had been on the experimental diets 
for 3-4 weeks were tised in the respiration studies, 
which were carried out in a small respiration chamber . 
(desiccator, 1.6 1). Air was drawn through the 
chamber and the trapping liquid (40 ml etha~o~am~~: 
ethyleneglycol monoethylester, 1:2)at - 300 ml/min. 
radioactivity was measured using the s~intil~atiort 
mixture [ 15 J which is especially. well suited for use 
with alkaline solutions containing large amounts of 
CO2 . ~dinzet~z3llmli??n - 14C]Aminopyrine, 3 2 Cilmol 
(Radiochemic~l Centre, Arnersham) was diluted with 
unlabeled aminopyrine (gift from Hoe&s% AG, 
Frankfurt) and used with a spec. act. 6 mCi/mol. 
L-[2-‘“C]Eistidine and [“%fformate were diluted 
with unlabeled material and used with a spec. act. 
2 mC$G~ol. These materials were injected i-p. to 
provide - 0.2 &i radioactivity/animal nd either 
5.15 mm01 aminopyrine, 1 mm01 histidine, or I mm01 
&mate/kg body wt. 
regimens for 3-g weeks prior to the experiment. Two 
series of experiments were carried out: the first con- 
sisting of groups i -_$ with W&tar rats. the secund of 
groups 5-8 with Sprague Dawley rats, 5 months after 
the first series. Group ? received rbgular 4aboratcry 
diet ~~ltromin), whereas all other groups were kept 
on a 20% soy protein diet low in methionine [2j 
supplemented with vitally Br2 ‘fS0 I;gjkg diet) and 
folic acid (2 n&kg tiiet). Group 3 received 
L-thyroxine (20 mgjkg diet) in order to produce 
thyrotoxicity, whereas group 4 received thiouraci: 
(1 g/kg diet) to produce hypothyroidism. 
In the second series (table 3-) the animals of 
groups 6-8 were thyroidectomized at weaning and 
placed on experimental diets 2 days later. 
-3. Results 
Phenobarbital pretreatment was performed by 
addition of sodium phenobarbital to the drinking 
water (1 g/l) for at least 7 days prior to the experiment. 
‘Pile animals were kept on different dietary 
Table 1 presents the results of an experiment 
comparing.the effects of rnethionine on the forrna- 
*ion of 1pCO2 ZroAm [dit71et~z~~Qzzzirzo-1~~~~~~~opy~~~~ 
in phenobar3itaf-pretreated rats kept on stock diet 
(group 1) or on a lo~v-~?~th~onine diet {groups 2-q). 
“C0, prodtiction was diminished by - 25% when 
the animals were kept cn a diet low in methionine as 
Table X 
Y02 exhalation from [Dime?i~~Jlam~~zlo-i4C]aminopyrine 
Group Diet Supplement “C02 exhaled <% of Dose of [ ‘T]am’nopyrine) 70~3 dne to 
no. per kg diet -. mcthionine 
L-Methionine L-Methionine L-Methionine at 1.3h 
atG5h at I.011 at I1.0 b 
+ _ + + 
-_ - 
1 Stock diet None 22.0 (3) 24.4 (31 32.9 (33 37-9 (3) 49.3 (6) 55.7 (3) 35 
TO.6 T2.1 20.8 52.3 A2.5 *1.2 
2 Low methiouine None 12.4 (4) 26.2 10 25.5 (4) 409 13) 39.9 (7) 55.0 (3) 60 
20.7 15.8 *I_2 +5.$ +I.3 23.3 
___- 
3 Low methiclnine L-;Ryroxine 12.2 (3) 21.0 (3) 24.0 (3) 38.6 (3) 33.7 (6) 53-2 (3) 62 
20 mg 11.5 16.4 ZCO.7 17-O dr2.8 f’3.5 
~-- 
4 Low methionine Thiouracil 15.5 (4) 28.6 (4) 30.4 (4) 422 (4) 45.6 (6) 53.7 (lh, 39 
Jg *2.7 IO.5 22.1 50.9 22.2 21.5 
.- 
Pretreatm; nt of the rats was performed as in section 2. Data are means t SEM. Number of animals in parenthews. 
L-Merhionfw was injected 30 min before start of experiment (: mmol/k~ bodjr wt). Aminopyrine (O.iS mmoi/kg body 
wt) was injected at zero time. All animals received p&enobarbital (I g/l) ia drinking water b@$nnning 7 days b&ore 
metabolism tests were made 
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Tatlble 2 
Effect of methionimc on ‘TO, exhalation from ‘T-labeled fomatc, aminopyrke and histidine ti 
nounal and thpoidectomi2ed rats pretreated with phenobarbital 
Group Treatment 14C0, exhaled (% of Dose) 
XIO. 
[ ‘fC]Formatea [dinies~~~~Lmi~20-‘4~~- [2-P4C]Histidineb 
E-methionine Aminopyrinea k-methionine 
L-methionine 
- 9 - + + 
5 ControP 28.5 33.4 32.1 42.8 
20.8 51.0 21.1 50.9 
6 Thyroidectomized 38.0 41.0 35.6 40.2 
*CL3 *I_9 *I_2 al .7 
7 Tbyroidectomized ; 30.4 30.7 22.7 48.4 
5 ~g T&W 5 I A 50.9 21.1 53.8 
8 Thyroidectomized; 32.4 37.0 34.3 50.7 
3 g thyroid powder/kg diet d.1 +2.1 T2.9 51.7 
a Values fox 3 R in respiration chamber 
b Values for 2 h in respiration &amber 
’ T, (9 0 pg) injected i.p. every other day; this represents replacement. Bevel of T= 
2.9 18.3 
50.3 50.6 
30.4 41.3 
e4.0 -+O.? 
2.5 16.9 
kO.3 *4.1 
1.9 32.1 
*O.B +2.6 
Values are percentage of injected dose oxidized to sesptiatory carbon dioxide in time indicated (2 SEM, 
~~5-61. L-Methionine (2 mmol/kg body w?) was injected X-30 min before injection of the label& 
compound. Arnorrn~s of injected compound (mm&/kg body wt): formate, 1.0; aminopyrine, 0.3; 
histidine, 1 .Q. Phenob~~ital-preleatment was as indicated in table f 
compared to that observed with the stock diet. The 
injection of Pnethionine (1 nxnol/kg body wt) 30 min 
before start of the experiment led to an increase (40%) 
in animak kept on the diet low in methionine. 
Methionine injection had a greater stinlulatory effect 
in animals kept on the low+nethionine diet than on 
the stock diet. 14C02 exhalation reached sin~ilar values 
after metRionine in~e+3n irrespective of the prior 
methionine supply with the diet (table 1). 
A further comparison of the effect of methioniw 
on the p4C0, fomation from [tgC]foormate, 
~d~~~etPny~~~~~~~o-‘4e]aminaopyr~Pie and [2-P4@]histidine 
is &10w~n in table 2. Clearly, there is an increase 
~II’~CO~ etialatiowfrom ~7i792es~2~17apn~920-24~~a~~slo- 
pyrine due to Hlnethionine in all the dietary treatments. 
The increase in folr>mate oxidation .in t41e same grolaps 
was smaller. These in xiv0 stirndatory effects of 
n-&Jiaionine injection may be compared with the much 
larger increases (- 3-fold) in ~~j~ne?~y~~~~~~~Pjo-B”@l 
aminopyrine oxidation and (w4-fo11d) 31 [“Cjformate 
OXS&OII olxxxved in perfnsed liver [I) and (---T&Id) 
inn ~l~~??ae~&y%~~9~ir2~-~~~~~~~~~y~~~ ofidation [a ] 
aHad [14C]~or~ate oxidation [4] in isolated hepato- 
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cytes. The stimulatory effect of methionine on 
WO* produczi on from p- ‘“C]bisiidine (table 2) was 
quite marked in the in viwo system, similar to Phe 
previous &dings wifh isolated hepxtocytes and per- 
fused sat liver [2G]. 
Thiouraeil feeding increased “C02 exhalation 
from labeled aminopyrine by 20% at 1 h (table 1: 
grooup 2 versus gpoplp, 41, and the increase observed 
after thyroidectomy WJS 11% (table 2: group 5 versus 
groug QUnder the same conditions thyroidectomized 
rats showed a BO-Sbld increased “C0, fwnation 
fro,, [2-‘“Cjkaistidine in these phenobarbital-pre- 
treaded antials, and formate oxidation was also 
increased by 33% (table 2: grooup 5 versus group 6). 
These observations indicate that in phenobarbital- 
pretreated animals fed a diet low in methior.line there 
is a P-estticted capacity to fobrID “COa frospp ~+?x?PBslyP- 
~nz&zP?o-n4C]anGnopyrine, [I4 C]fornIate and [-PC]- 
histidine. This restriction can be overcome by iwjec- 
Vdume 103, nlankr 2 FEBS LET-I-ERS July 1X& 
-eion of naetbionirre. Tbus, the nu&-Monal s.;atw 
re8ative to rnethionine intake or to vitamin Br2 
status which can affect rnethionine synthesis, could 
lead to alteratiogs in the extent of forn%e-CD2 
eonversion. This could be of relevance in the so-called 
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